Evidence map›Paper›PMID 41374880›Full record

ArticlePolymers2025

Development and Characterization of a Biodegradable Radiopaque PLA/Gd

Özkan Özmen, Sena Dursun

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Özkan ÖzmenDepartment of Industrial Design Engineering, Faculty of Engineering, Erciyes University, 38039 Kayseri, Türkiye.ORCID 0000-0001-9746-3500
Sena DursunGraduate School of Natural and Applied Sciences, Department of Industrial Design Engineering, Erciyes University, 38039 Kayseri, Türkiye.ORCID 0009-0002-8600-5138

Funding

Erciyes University Scientific Research Projects Coordination Unit FBA-2023-12864 and FAPD-2025-15180
6 · The paper itself

Abstract

Additive manufacturing (AM) has rapidly evolved due to its design flexibility, ability to enable personalized fabrication, and reduced material waste. In the medical field, fused filament fabrication (FFF) facilitates the production of individualized anatomical models for surgical preparation, education, medical imaging, and calibration. However, the lack of filaments with X-ray attenuation similar to that of biological hard tissues limits their use in radiological imaging. To address this limitation, a radiopaque filament was developed by incorporating gadolinium oxide (Gd

Indexed as

additive manufacturingbone-equivalent phantomcomputed tomographyfused filament fabricationradiopaque filamentX-ray imaging

Identifiers

PMID41374880
PMCPMC12693748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.